Section 68-5-805 - Reporting on variants of apolipoprotein L1The department shall conduct a review and issue a report to the general assembly on variants of the apolipoprotein L1 (APOL1) gene associated with increased risk of end-stage renal disease. The report must include:
(1) Recommendations on how to increase awareness for APOL1, including screening and genetic testing;(2) An analysis of strategies and funding to increase screening and genetic testing for APOL1 in this state; and(3) Other relevant information or issues identified by the department.Added by 2024 Tenn. Acts, ch. 838,s 1, eff. 5/1/2024.